Article Details
Retrieved on: 2024-10-02 16:16:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In addition to inclusion in START, the FDA has also granted AAV-Olig001-ASPA regenerative medicine advanced therapy (RMAT) designation, orphan drug ...
Article found on: www.cgtlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here